# China NMPA Drug Inspection - Guangdong Zaitian Pharmaceutical Co., Ltd. - Isatis root granules

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/guangdong-zaitian-pharmaceutical-co-ltd/a0feb9f5-1f6a-4547-9ce7-3b5b2feff937/
Source feed: China

> China NMPA drug inspection for Guangdong Zaitian Pharmaceutical Co., Ltd. published June 17, 2021. Drug: Isatis root granules. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Guangdong Provincial Drug Administration's Announcement Regarding Drug Sampling and Inspection Information (Issue 4, 2021)
- Company Name: Guangdong Zaitian Pharmaceutical Co., Ltd.
- Publication Date: 2021-06-17
- Drug Name: Isatis root granules
- Inspection Finding: Meets the requirements of drug standards (qualified)
- Action Taken: It does not involve the investigation and handling of substandard drugs.

Company: https://www.globalkeysolutions.net/companies/guangdong-zaitian-pharmaceutical-co-ltd/fe9651c2-6d76-40f0-bda0-4a5469c755e2/